These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 21633345)
1. Implications of obesity for drug therapy: limitations and challenges. Jain R; Chung SM; Jain L; Khurana M; Lau SW; Lee JE; Vaidyanathan J; Zadezensky I; Choe S; Sahajwalla CG Clin Pharmacol Ther; 2011 Jul; 90(1):77-89. PubMed ID: 21633345 [TBL] [Abstract][Full Text] [Related]
2. Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels. Willke RJ; Burke LB; Erickson P Control Clin Trials; 2004 Dec; 25(6):535-52. PubMed ID: 15588741 [TBL] [Abstract][Full Text] [Related]
3. Drug interactions and their nursing implications. Kuhn M J N Y State Nurses Assoc; 1993 Jun; 24(2):10-6. PubMed ID: 8366381 [TBL] [Abstract][Full Text] [Related]
4. Problems of drug administration in the pediatric patient. Yaffe SJ; Danish M Drug Metab Rev; 1978; 8(2):303-18. PubMed ID: 720215 [No Abstract] [Full Text] [Related]
5. [The effect of age, weight, sex and smoking habits on drug dosage]. Ochs HR; Verburg-Ochs B Internist (Berl); 1983 Mar; 24(3):167-81. PubMed ID: 6347943 [No Abstract] [Full Text] [Related]
6. Drug interactions evaluation: an integrated part of risk assessment of therapeutics. Zhang L; Reynolds KS; Zhao P; Huang SM Toxicol Appl Pharmacol; 2010 Mar; 243(2):134-45. PubMed ID: 20045016 [TBL] [Abstract][Full Text] [Related]
7. Modelling of drug disposition kinetics in in vitro intestinal absorption cell models. Heikkinen AT; Korjamo T; Mönkkönen J Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):180-8. PubMed ID: 20030630 [TBL] [Abstract][Full Text] [Related]
9. Lean-scaled weight: a proposed weight scalar to calculate drug doses for obese patients. Friesen JH Can J Anaesth; 2013 Feb; 60(2):214-5. PubMed ID: 23192695 [No Abstract] [Full Text] [Related]
10. Pharmacokinetic changes in critical illness. Boucher BA; Wood GC; Swanson JM Crit Care Clin; 2006 Apr; 22(2):255-71, vi. PubMed ID: 16677999 [TBL] [Abstract][Full Text] [Related]
11. Drug therapy in the elderly. Fruncillo RJ Am Fam Physician; 1987 Feb; 35(2):225-8. PubMed ID: 3812174 [No Abstract] [Full Text] [Related]
12. Using pharmacokinetics in drug therapy. VII: Pharmacokinetic factors influencing drug therapy in the aged. Schumacher GE Am J Hosp Pharm; 1980 Apr; 37(4):559-62. PubMed ID: 6990755 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and pharmacodynamic aspects of geriatric drug therapy. Edwards GB; Piepho RW Gerodontics; 1985 Aug; 1(4):160-4. PubMed ID: 3864709 [No Abstract] [Full Text] [Related]
14. Adipose tissue, insulin resistance and low-grade inflammation: implications for atherogenesis and the cardiovascular harm of estrogen plus progestogen therapy. Tankó LB; Christiansen C Climacteric; 2006 Jun; 9(3):169-80. PubMed ID: 16766431 [TBL] [Abstract][Full Text] [Related]
15. The effects of obesity on drug pharmacokinetics in humans. Morrish GA; Pai MP; Green B Expert Opin Drug Metab Toxicol; 2011 Jun; 7(6):697-706. PubMed ID: 21417960 [TBL] [Abstract][Full Text] [Related]
17. Predicting drug absorption: how nature made it a difficult problem. Burton PS; Goodwin JT; Vidmar TJ; Amore BM J Pharmacol Exp Ther; 2002 Dec; 303(3):889-95. PubMed ID: 12438506 [TBL] [Abstract][Full Text] [Related]
18. Drug-food and drug-nutrient interactions. Roe DA J Environ Pathol Toxicol Oncol; 1985 Jul; 5(6):115-35. PubMed ID: 3900336 [TBL] [Abstract][Full Text] [Related]
19. A discussion of drug metabolism and actions in the aged. Blumberg JB Drug Nutr Interact; 1985; 4(1-2):99-106. PubMed ID: 4075986 [No Abstract] [Full Text] [Related]
20. Influence of obesity on drug disposition. Blouin RA; Kolpek JH; Mann HJ Clin Pharm; 1987 Sep; 6(9):706-14. PubMed ID: 3315402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]